Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Ductal Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02782182
What this trial is testing

Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
University of Chicago 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT05642962
What this trial is testing

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma+10 more
Memorial Sloan Kettering Cancer Center 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07616362
What this trial is testing

Personalize (Signature Driven) Neoadjuvant Chemotherapy Trial for Patients With Resectable Borderline Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Federation Francophone de Cancerologie Digestive 110
Not applicableEnded earlyNCT04476537
What this trial is testing

RNA Precision Oncology in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Columbia University 16
Early research (Phase 1)Looking for participantsNCT06458712
What this trial is testing

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Who this might be right for
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)
Duke Street Bio Ltd 180
Testing effectiveness (Phase 2)UnknownNCT06467565
What this trial is testing

NALIRIFOX as Induction Therapy in LAPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Testing effectiveness (Phase 2)Ended earlyNCT04975516
What this trial is testing

Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8Recurrent Pancreatic Adenocarcinoma+1 more
Mayo Clinic 2
Not applicableUnknownNCT05997147
What this trial is testing

A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Predictive Cancer ModelPancreas Cancer
Tianjin Medical University Cancer Institute and Hospital 1,009
Not applicableUnknownNCT02928081
What this trial is testing

Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma

Who this might be right for
Carcinoma, Pancreatic Ductal
West China Hospital 320
Testing effectiveness (Phase 2)Active Not RecruitingNCT05945823
What this trial is testing

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Cancer+2 more
Taiho Oncology, Inc. 53
Large-scale testing (Phase 3)Active Not RecruitingNCT06783140
What this trial is testing

Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Advanced or MetastaticBRCA1/2 MutationPALB2 Gene Mutation
University Health Network, Toronto 10
Not applicableStudy completedNCT03257150
What this trial is testing

The Use of Irreversible Electroporation in Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University Health Network, Toronto 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06625320
What this trial is testing

Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic CancerPDACPDAC - Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 500
Testing effectiveness (Phase 2)WithdrawnNCT04134468
What this trial is testing

MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Abramson Cancer Center at Penn Medicine
Not applicableUnknownNCT02817308
What this trial is testing

Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas

Who this might be right for
Carcinoma, Pancreatic Ductal
Rambam Health Care Campus 100
Early research (Phase 1)Looking for participantsNCT04900818
What this trial is testing

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+5 more
I-Mab Biopharma US Limited 330
Early research (Phase 1)Active Not RecruitingNCT04523987
What this trial is testing

A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
National University Hospital, Singapore 10
Early research (Phase 1)Study completedNCT04106856
What this trial is testing

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more
University of Utah 22
Not applicableStudy completedNCT00644254
What this trial is testing

The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsPancreatic Adenocarcinoma
KU Leuven 145
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Next Page